CompletedNot Applicable

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

United States98 participantsStarted 2012-07

Plain-language summary

The purpose of this study is to determine if inadvertent receipt of the BioThrax vaccine during pregnancy is independently associated with adverse maternal, pregnancy, or infant health outcomes.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female active duty service member * Received one or more dose of BioThrax while pregnant, with the onset of pregnancy defined as the first day of the last menstrual period. Exclusion Criteria: * Non-service member, non-active duty pregnant female.

What they're measuring

Pregnancy Outcomes

Timeframe: Up to 44 weeks

Maternal Outcomes

Timeframe: Up to 44 weeks

Infant Outcomes

Timeframe: Up to 1 year of age

Trial details

NCT IDNCT01653392

SponsorEmergent BioSolutions

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-02

View on ClinicalTrials.gov More Pregnancy Complications trials